![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Biomagnetics Diagnostics Corp (CE) | USOTC:BMGP | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
Biomagnetics Diagnostics Corp., (PINK SHEETS: BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has begun the process of miniaturizing the optical biosensor platform developed in cooperation with Los Alamos National Laboratory. The Company has selected Silicon Valley-based Lathrop Engineering to assist in the finalization of the design.
On March 16th three engineers from Lathrop Engineering and personnel from Biomagnetics will meet with scientists at Los Alamos National Laboratories. Biomagnetics Diagnostics believes our portable, handheld technology will substantially lower the cost and raise the detection levels of, malaria, tuberculosis, HIV/AIDS and cholera diagnosis throughout the world, potentially saving hundreds of thousands of lives each year.
“This trip to Los Alamos will involve a complete update on our CRADA agreement, demonstration of our instrument and transfer of all design specs for the IOBS system to Lathrop Engineering,” commented Clayton Hardman, CEO of Biomagnetics. “Once Lathrop has the required documentation, they will submit a budget and timeline of the engineering requirements for both the hand held and laboratory systems of the IOBS unit. This is a major step in commercializing the IOBS system.”
About Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is currently developing a waveguide-based advanced integrated optical biosensor through its cooperative research and development agreement with Los Alamos National Security, LLC, which will initially be used for cholera, tuberculosis and malaria diagnosis. More information on Biomagnetics Diagnostics Corp. can be seen at www.biomagneticsbmgp.com.
1 Year Biomagnetics Diagnostics (CE) Chart |
1 Month Biomagnetics Diagnostics (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions